中国微创外科杂志
中國微創外科雜誌
중국미창외과잡지
CHINESE JOURNAL OF MINIMALLY INVASIVE SURGERY
2015年
2期
121-125
,共5页
徐遵礼%张前兴%朱建平%马利英
徐遵禮%張前興%硃建平%馬利英
서준례%장전흥%주건평%마리영
大体积前列腺增生%耻骨上前列腺切除术%经尿道前列腺电切术%经尿道前列腺剜除电切术%高危
大體積前列腺增生%恥骨上前列腺切除術%經尿道前列腺電切術%經尿道前列腺剜除電切術%高危
대체적전렬선증생%치골상전렬선절제술%경뇨도전렬선전절술%경뇨도전렬선완제전절술%고위
Large volume benign prostatic hyperplasia%Suprapubic prostatectomy%Transurethral resection of the prostate%Transurethral enucleation and resection of the prostate%High risk
目的:比较耻骨上前列腺切除术( suprapubic prostatectomy ,SP)、经尿道前列腺电切术( transurethral resection of the prostate,TURP)与经尿道前列腺剜除电切术( transurethral enucleation and resection of the prostate ,TUERP)治疗高危大体积前列腺增生患者的临床疗效和安全性。方法回顾性分析我院2005年7月~2014年3月手术治疗137例高危大体积前列腺增生患者的临床资料,以手术时期先后分别行SP(n=41)、TURP(n=42)和TUERP术(n=54)。比较3组手术时间、术后住院时间、腺体切除重量、术中出血量及术后国际前列腺症状评分、生活质量评分和膀胱残余尿等指标,并记录不良事件发生情况。结果137例手术均成功。手术时间SP组<TUERP 组<TURP组[(69.7±10.2) min vs.(80.9±16.6) min vs.(100.7±19.0) min, F=41.306, P=0.000]。腺体切除重量TUERP组和SP组>TURP组[(93.7±21.9) g vs.(101.9± 26.6) g vs.(80.0±18.5) g, F=10.107, P=0.000]。术中失血量TUERP组<SP组和TURP组(F=6.017, P=0.003)。术后住院时间TUERP组和TURP组<SP组[(8.6±1.1) d vs.(8.9±1.4) d vs.(13.1±2.8) d,F=80.727, P=0.000]。3组术后3个月国际前列腺症状评分、生活质量评分和膀胱残余尿等指标差异均无显著性( P>0.05)。结论 SP、TURP与TUERP治疗高危大体积前列腺增生均安全、有效。 TUERP具有切除腺体彻底、手术时间短、出血少、术后恢复快的优点。
目的:比較恥骨上前列腺切除術( suprapubic prostatectomy ,SP)、經尿道前列腺電切術( transurethral resection of the prostate,TURP)與經尿道前列腺剜除電切術( transurethral enucleation and resection of the prostate ,TUERP)治療高危大體積前列腺增生患者的臨床療效和安全性。方法迴顧性分析我院2005年7月~2014年3月手術治療137例高危大體積前列腺增生患者的臨床資料,以手術時期先後分彆行SP(n=41)、TURP(n=42)和TUERP術(n=54)。比較3組手術時間、術後住院時間、腺體切除重量、術中齣血量及術後國際前列腺癥狀評分、生活質量評分和膀胱殘餘尿等指標,併記錄不良事件髮生情況。結果137例手術均成功。手術時間SP組<TUERP 組<TURP組[(69.7±10.2) min vs.(80.9±16.6) min vs.(100.7±19.0) min, F=41.306, P=0.000]。腺體切除重量TUERP組和SP組>TURP組[(93.7±21.9) g vs.(101.9± 26.6) g vs.(80.0±18.5) g, F=10.107, P=0.000]。術中失血量TUERP組<SP組和TURP組(F=6.017, P=0.003)。術後住院時間TUERP組和TURP組<SP組[(8.6±1.1) d vs.(8.9±1.4) d vs.(13.1±2.8) d,F=80.727, P=0.000]。3組術後3箇月國際前列腺癥狀評分、生活質量評分和膀胱殘餘尿等指標差異均無顯著性( P>0.05)。結論 SP、TURP與TUERP治療高危大體積前列腺增生均安全、有效。 TUERP具有切除腺體徹底、手術時間短、齣血少、術後恢複快的優點。
목적:비교치골상전렬선절제술( suprapubic prostatectomy ,SP)、경뇨도전렬선전절술( transurethral resection of the prostate,TURP)여경뇨도전렬선완제전절술( transurethral enucleation and resection of the prostate ,TUERP)치료고위대체적전렬선증생환자적림상료효화안전성。방법회고성분석아원2005년7월~2014년3월수술치료137례고위대체적전렬선증생환자적림상자료,이수술시기선후분별행SP(n=41)、TURP(n=42)화TUERP술(n=54)。비교3조수술시간、술후주원시간、선체절제중량、술중출혈량급술후국제전렬선증상평분、생활질량평분화방광잔여뇨등지표,병기록불량사건발생정황。결과137례수술균성공。수술시간SP조<TUERP 조<TURP조[(69.7±10.2) min vs.(80.9±16.6) min vs.(100.7±19.0) min, F=41.306, P=0.000]。선체절제중량TUERP조화SP조>TURP조[(93.7±21.9) g vs.(101.9± 26.6) g vs.(80.0±18.5) g, F=10.107, P=0.000]。술중실혈량TUERP조<SP조화TURP조(F=6.017, P=0.003)。술후주원시간TUERP조화TURP조<SP조[(8.6±1.1) d vs.(8.9±1.4) d vs.(13.1±2.8) d,F=80.727, P=0.000]。3조술후3개월국제전렬선증상평분、생활질량평분화방광잔여뇨등지표차이균무현저성( P>0.05)。결론 SP、TURP여TUERP치료고위대체적전렬선증생균안전、유효。 TUERP구유절제선체철저、수술시간단、출혈소、술후회복쾌적우점。
Objective To compare the efficacy and safety of suprapubic prostatectomy (SP), transurethral resection of the prostate (TURP), and transurethral enucleation and resection of the prostate (TUERP) for high risk large volume benign prostatic hyperplasia ( BPH) . Methods A total of 137 high risk patients with large volume BPH who underwent operations in our hospital from July 2005 to March 2014 were divided into either SP group (n=41), or TURP group (n=42), or TUERP group (n=54).The operation time, hospital stay after operation, weight of prostate removed, intraoperative blood loss, IPSS, QOL, and PVR were compared among the three groups .Adverse events were recorded . Results The operations were successfully completed in all the 137 cases.The operation time showed that SP <TUERP<TURP [(69.7 ±10.2) min vs.(80.9 ±16.6) min vs.(100.7 ±19.0) min, F=41.306, P=0.000].The weight of prostate removed showed TUERP and SP >TURP [(93.7 ±21.9) g vs.(101.9 ±26.6) g vs.(80.0 ±18.5) g, F=10.107, P=0.000].The intraoperative blood loss showed TUERP <SP and TURP ( F=6.017, P=0.003).The postoperative hospital stay showed TUERP and TURP <SP [(8.6 ±1.1) d vs.(8.9 ±1.4) d vs.(13.1 ±2.8) d, F=80.727, P=0.000].There were no significant differences in IPSS , QOL, and PVR at 3 months after operation among the three groups (P>0.05). Conclusions All of the SP, TURP, and TUERP are safe and effect for the treatment of high risk patients with large volume BPH.TUERP has advantages of better gland removal rate , shorter operation time, less bleeding, and faster postoperative recovery.